Adam G. Gerhardt

Adam G. Gerhardt

Auto-generated profile, based on publicly available information

Adam G. Gerhardt

Comprehensive Cancer Center, The Ohio State University , Columbus, OH 43210

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2020 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
ANAnsel P. Nalin
Ansel P. Nalin
JKJesse J. Kowalski
Jesse J. Kowalski
ASAlexander C. Sprague
Alexander C. Sprague
BSBlaire K. Schumacher
Blaire K. Schumacher
AGAdam G. Gerhardt
Adam G. Gerhardt
AFAharon G. Freud
Aharon G. Freud
Human NK cells develop in tonsils through discrete NK cell developmental intermediates (NKDIs), yet the mechanistic regulation of this process is unclear. We demonstrate that Notch activation in human tonsil-derived stage 3 (CD34−CD117+CD94−NKp80−) and 4A (CD34−CD117+/−CD94+NKp80−) NKDIs promoted non–NK innate lymphoid cell differentiation at the expense of NK cell differentiation. In contrast, stage 4B (CD34−CD117+/−CD94+NKp80+) NKDIs were NK cell lineage committed despite Notch activation. Interestingly, whereas NK cell functional maturation from stage 3 and 4A NKDIs was independent of Notch activation, the latter was required for high NKp80 expression and a stage 4B–like phenotype by the NKDI-derived NK cells. The Notch-dependent effects required simultaneous engagement with OP9 stromal cells and were also stage-specific, with NOTCH1 and NOTCH2 receptors regulating stage 3 NKDIs and NOTCH1 primarily regulating stage 4A NKDIs. These data establish stage-specific and stromal-dependent roles for Notch in regulating human NK cell developmental plasticity and maturation. Key Points Stage 3 and 4A but not 4B NKDIs retain non–NK ILC developmental potential. Notch activation in the presence of stroma promotes ILC2 and ILC3 differentiation. NOTCH1 and NOTCH2 regulate ILC differentiation from stage 3 and 4A cells.